TS vs. ABBV
Compare and contrast key facts about Tenaris S.A. (TS) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TS or ABBV.
Correlation
The correlation between TS and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
TS vs. ABBV - Performance Comparison
Loading data...
Key characteristics
TS:
0.03
ABBV:
0.57
TS:
0.24
ABBV:
0.96
TS:
1.03
ABBV:
1.15
TS:
0.02
ABBV:
0.87
TS:
0.08
ABBV:
2.07
TS:
10.55%
ABBV:
8.72%
TS:
30.04%
ABBV:
28.31%
TS:
-82.89%
ABBV:
-45.09%
TS:
-26.87%
ABBV:
-14.28%
Fundamentals
TS:
$18.37B
ABBV:
$325.05B
TS:
$3.28
ABBV:
$2.37
TS:
10.40
ABBV:
77.65
TS:
4.69
ABBV:
0.39
TS:
1.53
ABBV:
5.67
TS:
1.07
ABBV:
228.91
TS:
$12.00B
ABBV:
$57.37B
TS:
$4.08B
ABBV:
$44.44B
TS:
$2.80B
ABBV:
$16.33B
Returns By Period
In the year-to-date period, TS achieves a -9.74% return, which is significantly lower than ABBV's 5.50% return. Over the past 10 years, TS has underperformed ABBV with an annualized return of 4.61%, while ABBV has yielded a comparatively higher 15.58% annualized return.
TS
-9.74%
2.56%
-6.46%
0.90%
23.67%
4.61%
ABBV
5.50%
6.38%
13.63%
14.60%
19.88%
15.58%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TS vs. ABBV — Risk-Adjusted Performance Rank
TS
ABBV
TS vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tenaris S.A. (TS) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TS vs. ABBV - Dividend Comparison
TS's dividend yield for the trailing twelve months is around 3.93%, more than ABBV's 3.47% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TS Tenaris S.A. | 3.93% | 3.55% | 3.11% | 2.56% | 2.59% | 4.39% | 3.62% | 3.85% | 2.57% | 2.41% | 3.78% | 2.98% |
ABBV AbbVie Inc. | 3.47% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
TS vs. ABBV - Drawdown Comparison
The maximum TS drawdown since its inception was -82.89%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for TS and ABBV. For additional features, visit the drawdowns tool.
Loading data...
Volatility
TS vs. ABBV - Volatility Comparison
The current volatility for Tenaris S.A. (TS) is 6.10%, while AbbVie Inc. (ABBV) has a volatility of 11.11%. This indicates that TS experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TS vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Tenaris S.A. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TS vs. ABBV - Profitability Comparison
TS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Tenaris S.A. reported a gross profit of 1.00B and revenue of 2.92B. Therefore, the gross margin over that period was 34.3%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
TS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Tenaris S.A. reported an operating income of 549.91M and revenue of 2.92B, resulting in an operating margin of 18.8%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
TS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Tenaris S.A. reported a net income of 506.93M and revenue of 2.92B, resulting in a net margin of 17.4%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.